Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Depreciation & Amortization (CF) (2020 - 2022)

Historic Depreciation & Amortization (CF) for Pharming (PHAR) over the last 3 years, with Q4 2022 value amounting to $2.2 million.

  • Pharming's Depreciation & Amortization (CF) rose 615.61% to $2.2 million in Q4 2022 from the same period last year, while for Sep 2023 it was $2.2 million, marking a year-over-year increase of 583.72%. This contributed to the annual value of $8.3 million for FY2020, which is 4332.01% up from last year.
  • As of Q4 2022, Pharming's Depreciation & Amortization (CF) stood at $2.2 million, which was up 615.61% from -$4.3 million recorded in Q3 2022.
  • Pharming's 5-year Depreciation & Amortization (CF) high stood at $2.3 million for Q3 2020, and its period low was -$4.4 million during Q3 2021.
  • For the 3-year period, Pharming's Depreciation & Amortization (CF) averaged around $269916.2, with its median value being $2.1 million (2021).
  • Data for Pharming's Depreciation & Amortization (CF) shows a peak YoY increase of 2368070.4% (in 2021) and a maximum YoY decrease of 29163.23% (in 2021) over the last 5 years.
  • Over the past 3 years, Pharming's Depreciation & Amortization (CF) (Quarter) stood at $8675.1 in 2020, then soared by 23680.7% to $2.1 million in 2021, then grew by 6.16% to $2.2 million in 2022.
  • Its last three reported values are $2.2 million in Q4 2022, -$4.3 million for Q3 2022, and $2.1 million during Q2 2022.